NK cell activation and tumor lysis occur through a complex interaction between triggering receptors such as NKp30, NKp44, NKp46 and NKG2D with tumor cell ligands, in fine balance with inhibitory receptors and co-receptors [14]. This evidence concerns the gene NCR2 and neoplasm.